356 related articles for article (PubMed ID: 9593134)
1. Levofloxacin population pharmacokinetics and creation of a demographic model for prediction of individual drug clearance in patients with serious community-acquired infection.
Preston SL; Drusano GL; Berman AL; Fowler CL; Chow AT; Dornseif B; Reichl V; Natarajan J; Wong FA; Corrado M
Antimicrob Agents Chemother; 1998 May; 42(5):1098-104. PubMed ID: 9593134
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetics of oral levofloxacin 500 mg once-daily dosage in community-acquired lower respiratory tract infections: results of a prospective multicenter study in China.
Zhang J; Xu JF; Liu YB; Xiao ZK; Huang JA; Si B; Sun SH; Xia QM; Wu XJ; Cao GY; Shi YG; Zhang YY
J Infect Chemother; 2009 Oct; 15(5):293-300. PubMed ID: 19856067
[TBL] [Abstract][Full Text] [Related]
3. Double-blind evaluation of the safety and pharmacokinetics of multiple oral once-daily 750-milligram and 1-gram doses of levofloxacin in healthy volunteers.
Chien SC; Wong FA; Fowler CL; Callery-D'Amico SV; Williams RR; Nayak R; Chow AT
Antimicrob Agents Chemother; 1998 Apr; 42(4):885-8. PubMed ID: 9559801
[TBL] [Abstract][Full Text] [Related]
4. The clinical pharmacokinetics of levofloxacin.
Fish DN; Chow AT
Clin Pharmacokinet; 1997 Feb; 32(2):101-19. PubMed ID: 9068926
[TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials.
Preston SL; Drusano GL; Berman AL; Fowler CL; Chow AT; Dornseif B; Reichl V; Natarajan J; Corrado M
JAMA; 1998 Jan; 279(2):125-9. PubMed ID: 9440662
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and pharmacodynamics of levofloxacin in intensive care patients.
Sánchez Navarro A; Colino Gandarillas CI; Alvarez Lerma F; Menacho YA; Domínguez-Gil A
Clin Pharmacokinet; 2005; 44(6):627-35. PubMed ID: 15910010
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and safety of oral levofloxacin in human immunodeficiency virus-infected individuals receiving concomitant zidovudine.
Chien SC; Chow AT; Rogge MC; Williams RR; Hendrix CW
Antimicrob Agents Chemother; 1997 Aug; 41(8):1765-9. PubMed ID: 9257757
[TBL] [Abstract][Full Text] [Related]
8. Levofloxacin pharmacokinetics in ESRD and removal by the cellulose acetate high performance-210 hemodialyzer.
Sowinski KM; Lucksiri A; Kays MB; Scott MK; Mueller BA; Hamburger RJ
Am J Kidney Dis; 2003 Aug; 42(2):342-9. PubMed ID: 12900817
[TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamics of levofloxacin and ciprofloxacin in a murine pneumonia model: peak concentration/MIC versus area under the curve/MIC ratios.
Scaglione F; Mouton JW; Mattina R; Fraschini F
Antimicrob Agents Chemother; 2003 Sep; 47(9):2749-55. PubMed ID: 12936969
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamic profiling of levofloxacin and gatifloxacin using Monte Carlo simulation for community-acquired isolates of Streptococcus pneumoniae.
Nicolau DP; Ambrose PG
Am J Med; 2001 Dec; 111 Suppl 9A():13S-18S; discussion 36S-38S. PubMed ID: 11755438
[TBL] [Abstract][Full Text] [Related]
11. Relevance of soft-tissue penetration by levofloxacin for target site bacterial killing in patients with sepsis.
Zeitlinger MA; Dehghanyar P; Mayer BX; Schenk BS; Neckel U; Heinz G; Georgopoulos A; Müller M; Joukhadar C
Antimicrob Agents Chemother; 2003 Nov; 47(11):3548-53. PubMed ID: 14576116
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics and maximum a posteriori probability Bayesian estimator of abacavir: application of individualized therapy in HIV-infected infants and toddlers.
Zhao W; Cella M; Della Pasqua O; Burger D; Jacqz-Aigrain E;
Br J Clin Pharmacol; 2012 Apr; 73(4):641-50. PubMed ID: 21988586
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and intrapulmonary diffusion of levofloxacin in critically ill patients with severe community-acquired pneumonia.
Boselli E; Breilh D; Rimmelé T; Djabarouti S; Saux MC; Chassard D; Allaouchiche B
Crit Care Med; 2005 Jan; 33(1):104-9. PubMed ID: 15644655
[TBL] [Abstract][Full Text] [Related]
14. Intrapulmonary pharmacokinetics and pharmacodynamics of high-dose levofloxacin in healthy volunteer subjects.
Conte JE; Golden JA; McIver M; Zurlinden E
Int J Antimicrob Agents; 2006 Aug; 28(2):114-21. PubMed ID: 16837169
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of intravenous and oral levofloxacin in critically ill adults in a medical intensive care unit.
Rebuck JA; Fish DN; Abraham E
Pharmacotherapy; 2002 Oct; 22(10):1216-25. PubMed ID: 12389872
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamic target attainment analysis against Streptococcus pneumoniae using levofloxacin 500 mg, 750 mg and 1000 mg once daily in plasma (P) and epithelial lining fluid (ELF) of hospitalized patients with community acquired pneumonia (CAP).
Noreddin AM; Marras TK; Sanders K; Chan CK; Hoban DJ; Zhanel GG
Int J Antimicrob Agents; 2004 Nov; 24(5):479-84. PubMed ID: 15519481
[TBL] [Abstract][Full Text] [Related]
17. Comparison of gatifloxacin and levofloxacin administered at various dosing regimens to hospitalised patients with community-acquired pneumonia: pharmacodynamic target attainment study using North American surveillance data for Streptococcus pneumoniae.
Noreddin AM; Hoban DJ; Zhanel GG
Int J Antimicrob Agents; 2005 Aug; 26(2):120-5. PubMed ID: 16046101
[TBL] [Abstract][Full Text] [Related]
18. Ciprofloxacin pharmacokinetics in burn patients.
Garrelts JC; Jost G; Kowalsky SF; Krol GJ; Lettieri JT
Antimicrob Agents Chemother; 1996 May; 40(5):1153-6. PubMed ID: 8723457
[TBL] [Abstract][Full Text] [Related]
19. Effects of food and sucralfate on a single oral dose of 500 milligrams of levofloxacin in healthy subjects.
Lee LJ; Hafkin B; Lee ID; Hoh J; Dix R
Antimicrob Agents Chemother; 1997 Oct; 41(10):2196-200. PubMed ID: 9333047
[TBL] [Abstract][Full Text] [Related]
20. Development of a population pharmacokinetic model and optimal sampling strategies for intravenous ciprofloxacin.
Forrest A; Ballow CH; Nix DE; Birmingham MC; Schentag JJ
Antimicrob Agents Chemother; 1993 May; 37(5):1065-72. PubMed ID: 8517693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
